Jingmei Li

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. doi Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
    J Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
    Ann Oncol 26:517-22. 2015
  2. pmc Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
    Jingmei Li
    Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
    Breast Cancer Res 12:R19. 2010
  3. pmc Effects of childhood body size on breast cancer tumour characteristics
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 12:R23. 2010
  4. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
  5. pmc Coffee consumption modifies risk of estrogen-receptor negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 13:R49. 2011
  6. doi A combined analysis of genome-wide association studies in breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 17177 Stockholm, Sweden
    Breast Cancer Res Treat 126:717-27. 2011
  7. pmc Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer
    Abbas Cheddad
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 9:e110690. 2014
  8. doi Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 23:1764-72. 2014
  9. pmc Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer
    Jingmei Li
    Genome Institute of Singapore, Singapore
    J Clin Oncol 31:2249-56. 2013
  10. pmc The genetic basis of quality of life in healthy Swedish women: a candidate gene approach
    Dounya Schoormans
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
    PLoS ONE 10:e0118292. 2015

Detail Information

Publications11

  1. doi Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
    J Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
    Ann Oncol 26:517-22. 2015
    ..We evaluated whether this genetic risk stratification can also be applied to discriminate between screen-detected and interval cancers, which are usually associated with clinicopathological and survival differences...
  2. pmc Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
    Jingmei Li
    Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
    Breast Cancer Res 12:R19. 2010
    ..In this study, we evaluate the association between mammographic density and genetic variants of the estrogen metabolic pathway...
  3. pmc Effects of childhood body size on breast cancer tumour characteristics
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 12:R23. 2010
    ..Although a role of childhood body size in postmenopausal breast cancer risk has been established, less is known about its influence on tumour characteristics...
  4. pmc A genome-wide association scan on estrogen receptor-negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
    Breast Cancer Res 12:R93. 2010
    ..ER status of breast cancer is important clinically, and is used both as a prognostic indicator and treatment predictor. In this study, we focused on identifying genetic markers associated with ER-negative breast cancer risk...
  5. pmc Coffee consumption modifies risk of estrogen-receptor negative breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 13:R49. 2011
    ..We assessed the association between coffee consumption and postmenopausal breast cancer risk in a large population-based study (2,818 cases and 3,111 controls), overall, and stratified by ER tumour subtypes...
  6. doi A combined analysis of genome-wide association studies in breast cancer
    Jingmei Li
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 17177 Stockholm, Sweden
    Breast Cancer Res Treat 126:717-27. 2011
    ..More effort focused in these aspects of oncology can potentially open up promising avenues for the understanding of breast cancer and its prevention...
  7. pmc Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer
    Abbas Cheddad
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 9:e110690. 2014
    ..We describe fully automated methods for measuring both area and volumetric mammographic density from processed images...
  8. doi Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment
    Judith S Brand
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 23:1764-72. 2014
    ..We evaluated the performance of a fully automated volumetric method (Volpara)...
  9. pmc Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer
    Jingmei Li
    Genome Institute of Singapore, Singapore
    J Clin Oncol 31:2249-56. 2013
    ..However, the extent to which change in mammographic density during adjuvant tamoxifen therapy can be used to measure response to treatment is unknown...
  10. pmc The genetic basis of quality of life in healthy Swedish women: a candidate gene approach
    Dounya Schoormans
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
    PLoS ONE 10:e0118292. 2015
    ..It is hypothesized that one may have a genetic predisposition for QoL. We therefore related 139 candidate genes, selected through a literature search, to QoL in healthy females...
  11. doi Enhancement of mammographic density measures in breast cancer risk prediction
    Abbas Cheddad
    Authors Affiliations Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 23:1314-23. 2014
    ..Mammographic density is a strong risk factor for breast cancer...